Table 3

Sensitivity tests of developing type 2 DM among adolescents and young adults with and without ASD

Total≥1 year≥3 years
HR (95% CI)HR (95% CI)HR (95% CI)
ASD*
 Absence111
 Presence3.25 (2.23–4.75)3.03 (2.03–4.51)2.62 (1.62–4.23)
  • Boldface type indicates statistical significance. *Adjusted for demographic data, use of atypical antipsychotics, and medical comorbidities and ASD as a binary variable.